Complete disappearance of uptake of FDG in the multifocal liver hemangioendothelioma after radioembolization therapy using yttrium-90 microspheres.

Abstract

Hemangioendothelioma (HE) is an intermediate grade tumor that originates from vascular endothelium. It is rarely encountered in the liver as multifocal lesions. In the treatment of the hepatic HE, surgical resection, chemotherapy, interferon-alpha 2 therapy and liver transplantation have been described in the literature. Intra-arterial radioembolization therapy with yttrium-90 microsphere is an advanced and promising technique in the treatment of hepatic multifocal HEs. In this report, we aimed to present pre- and post-treatment radio-nuclear imaging features and to discuss radioembolization technique in a 56-year-old patient with multifocal liver HE.

• Authors: Bulent Karaman, Bilal Battal, Engin Alagoz, Veysel Akgun, Selami Ince, Bahri Ustunsoz
• Journal: Annals of nuclear medicine (Ann Nucl Med) Vol. 26 Issue 5 Pg. 440-3 (Jun 2012) ISSN: 1864-6433 [Electronic] Japan
• PMID: 22438115 (Publication Type: Case Reports, Journal Article)

Chemical References

• Yttrium Radioisotopes
• Fluorodeoxyglucose F18

Topics

• Biological Transport
• Embolization, Therapeutic
• Fluorodeoxyglucose F18 (metabolism)
• Hemangioendothelioma (diagnostic imaging, metabolism, therapy)
• Humans
• Liver Neoplasms (diagnostic imaging, metabolism, therapy)
• Male
• Microspheres
• Middle Aged
• Positron-Emission Tomography
• Tomography, X-Ray Computed
• Treatment Outcome
• Yttrium Radioisotopes (chemistry, therapeutic use)